Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117329) titled 'Pharmacodynamic Analysis of Intravenous Remimazolam Tosylate for Sedation in Obese Patients: A Prospective, Double-Blind, Single-Center, Randomized Clinical Trial' on Jan. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital, Sun Yat-sen University
Condition:
Obesity
Intervention:
non-obese group,:Patients within each group were randomly assigned to receive one of five doses of remimazolam tosylate - 0.07, 0.12, 0.17, 0.22, or 0.27 mg·kg-1 - for anesthesia induction.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-0...